Advances in Glycobiotechnology

CHF 333.55
Auf Lager
SKU
81BSM8SBVPO
Stock 1 Verfügbar
Geliefert zwischen Mi., 25.02.2026 und Do., 26.02.2026

Details

Outlines recombinant glycoprotein expression in different host systems

Discusses the role of glycosylation on protein function and vaccine development

Updates on cutting edge glycoanalytical technologies

Sets out future directions in glycobiotechnology and glycoanalysis



Outlines recombinant glycoprotein expression in different host systems Discusses the role of glycosylation on protein function and vaccine development Updates on cutting edge glycoanalytical technologies Sets out future directions in glycobiotechnology and glycoanalysis

Autorentext

Dr. Erdmann Rapp is heading the Bio/Process Analytics team of the Bioprocess Engineering Department at the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg and founder, CEO & CSO of glyXera, providing tailored cutting-edge glycoanalytical products and services. He is an experienced researcher, inventor, mentor and university lecturer. He and his team are working on the development and implementation of innovative bio/process analytics - in particular, on sophisticated tools for proteomics, glycoproteomics and glycomics - for a deeper understanding of biological and biotechnological processes. Dr. Rapp's successful research is documented by more than 120 peer-reviewed papers and book chapters, and 8 patents.Professor Udo Reichl is a Scientific Member of the Max Planck Society, Director of the Bioprocess Engineering Department of the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg and Chair of Bioprocess Engineering at the Otto-von-Guericke University Magdeburg. He has profound expertise in the development and optimization of cell culture-based viral vaccine production. His group developed sophisticated analytical tools to monitor process dynamics, metabolism of cell lines, infection dynamics and the glycosylation of viral and recombinant proteins. His list of publications comprises more than 250 peer-reviewed papers and book chapters, and he has filed various patents.


Inhalt
Glyco-engineering of mammalian expression systems on process level.- Glyco-engineering of mammalian expression systems on cellular level.- Glyco-engineering of insect cell expression systems.- Glyco-engineering of yeast expression systems.- Glyco-engineering of plant(cell) expression systems.- Glyco-engineering of bacteria expression systems.- Chemical synthesis of glycans and glycoconjugates.- Enzymatic synthesis of glycans and glycoconjugates.- The interplay/impact of glycosylation and/on protein function for recombinant proteins and mAbs.- The interplay/impact of glycosylation and/on protein function for recombinant proteins and mAbs.- The interplay/impact of glycosylation and/on protein function for bacterial vaccines.- Glycomicstechnologies.- Glycoproteomicstechnologies.- Glycan array technologies.

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Anzahl Seiten 472
    • Herausgeber Springer International Publishing
    • Gewicht 709g
    • Untertitel Advances in Biochemical Engineering/Biotechnology 175
    • Titel Advances in Glycobiotechnology
    • Veröffentlichung 03.07.2022
    • ISBN 3030695921
    • Format Kartonierter Einband
    • EAN 9783030695927
    • Jahr 2022
    • Größe H235mm x B155mm x T26mm
    • Lesemotiv Verstehen
    • Editor Erdmann Rapp, Udo Reichl
    • Auflage 1st edition 2021
    • GTIN 09783030695927

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470
Kundenservice: customerservice@avento.shop | Tel: +41 44 248 38 38